Clinical Trial Update: 89Zr-AMG211 PET Imaging Study [Phase 1]

View source ↗

Summary

Phase 1 PET imaging study using 89Zr-labeled AMG211 in patients with advanced gastrointestinal cancer has completed. The sponsor is University Medical Center Gr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• 89Zr-AMG211 (AMG211)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Advanced Gastrointestinal Cancer | Phase 1 | Status: COMPLETED